Prof. Francesc Bosch AlbaredaProf. of Hematology & Head of the Dept. of Hematology
University Hospital Vall d’Hebron, Barcelona
Francesc is a Professor of Hematology and Head of the Department of Hematology in University Hospital Vall d’Hebron, Barcelona. He graduated from Medical School at the University of Barcelona. Between 1989 and 1992 he obtained his Hematology training as a resident at Hospital Clinic of Barcelona. In 1997 he was awarded a PhD by the University of Barcelona for his research on the over-expression of Cyclin D1 in chronic lymphoproliferative disorders under the supervision of Professor Elias Campo. He subsequently did a two-year postdoctoral stay in the laboratory of Professor Riccardo Dalla-Favera at the Institute of Cancer Genetics, Columbia University, New York. He moved back to Hospital Clinic in Barcelona in 2000 where he continued doing research in CLL.
In 2009, Francesc became Head of the Department of Hematology and Director of the Experimental Hematology laboratory at the University Hospital Vall d’Hebron in Barcelona where he conducts both clinical and basic research in CLL and other lymphoproliferative disorders, particularly focusing in the molecular pathogenesis of CLL and in the development of novel therapeutic approaches.
For more than two decades he has been involved in the development of clinical trials in CLL, performing seminal contributions in the prognosis assessment and treatment of CLL. He currently chairs the Spanish CLL Working Group (GELLC), responsible for the development of Spanish CLL Clinical trials. He has published more than a hundred papers in peer-reviewed journals such as The New England Journal of Medicine, Nature Medicine, Cancer Cell, Blood, Journal of Clinical Oncology, and Leukemia. In addition, he has authored or co-authored several Reviews and Book Chapters on the subject of CLL and other lymphoproliferative disorders.